Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease
- 20 March 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 575 (2) , 285-298
- https://doi.org/10.1016/0006-8993(92)90092-n
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- A substrate amplification system for enzyme-linked immunoassays: Demonstration of its general applicability to ELISA systems for detecting antibodies and immune complexesJournal of Immunological Methods, 1987
- A substrate amplification system for enzyme-linked immunoassaysJournal of Immunological Methods, 1987
- PARKINSONISM AND INDUSTRIAL CHEMICALSThe Lancet, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Smoking, cancer, and Parkinson's diseaseAnnals of Neurology, 1986
- Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in rana pipiensLife Sciences, 1985
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse liver preparationsBiochemical and Biophysical Research Communications, 1984
- Parkinsonism‐dementia in a Filipino migrantNeurology, 1982